Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Glibenclamide

A second-generation sulfonylurea that prompts the pancreas to release insulin, developed in Germany in the late 1960s for type 2 diabetes; in the United States it is known as glyburide. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.

Did you know?After a stroke the damaged blood-brain barrier lets it reach the brain, where it binds mainly to the affected hemisphere: this is why it is also being studied in neurology.

GlibenclamideGo to the active ingredient →
GlibenclamideActive ingredientGlibenclamideCat. No. P-G038-001CAS 10238-21-8
Glyburide-d11Isotopically labelledGlyburide-d11Cat. No. P-G038-006CAS 1189985-02-1
Glyburide-d3Isotopically labelledGlyburide-d3Cat. No. P-G038-007CAS 1219803-02-7

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.